Experimental Eye Research, 83 (6), 1366-1372
Ethical principles of the study complied with the European Directive 010/63/E, the Law on Amendments to the Animal Protection Act (Official Gazette 37/13), the Animal Protection Act (Official Gazette 135/06), the ordinance on the protection of animals used for scientific purposes (Official Gazette 55/13), Federation of European Laboratory Animal Science Associations (FELASA) recommendations, and the recommendations of the Ethics Committee of the School of Medicine, University of Zagreb
Our commitment to quality means each vial undergoes rigorous third-party testing to confirm purity levels of 98%, accurate sequence verification via mass spectrometry, copper content validation, and structural confirmation via HPLC
This preparation contains 20 mg of high purity lyophilized peptide supplied in a sealed research vial
G0438 and G0439 are covered under Medicares Annual Wellness Visit benefit